Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Zylacta

Zylacta
2004 FOUNDED
PRIVATE STATUS
Accelerator/Inc LATEST DEAL TYPE
$254K LATEST DEAL AMOUNT
2 INVESTORS
Description

Operator of a biotechnology company intended to develop small molecule therapeutics. The company's biotechnology process offers therapeutics based on bacterial cell wall peptidoglycan for immunotherapy and also offers methods to develop these hits into drugs via a gene-based technology, enabling clients to get expertise in genomics of bacterial peptidoglycan synthesis, maturation and shedding.

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 7965 Cessna Avenue
  • Gaithersburg, MD 20879
  • United States

+1 (410) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Zylacta’s full profile, request a free trial.

Zylacta Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Accelerator/Incubator 21-Feb-2008 $254K 00000 Completed Startup
2. Early Stage VC 03-Nov-2006 00000 00000 Completed Startup
1. Grant 26-Sep-2006 $75K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Zylacta Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Maryland Industrial Partnerships Accelerator/Incubator 000 0000 000000 0
TEDCO Venture Capital Minority 000 0000 000000 0

Zylacta Executive Team (3)

Name Title Board
Seat
Contact
Info
Robert Shalwitz MD Co-Founder & President
Vladimir Slesarev Ph.D Co-Founder & Advisor

1 Former Executive

You’re viewing 2 of 3 executives. Get the full list »